Carbon Quantum Dots for the Diagnosis and Treatment of Ophthalmic Diseases

Overview

Journal Hum Cell

Publisher Springer

Specialty Cell Biology

Date 2024 Aug 2

PMID 39093514

Authors

Xi Zhang

Liang Yang

Feng Wang

Ying Su

Affiliations

Soon will be listed here.

Abstract

Carbon quantum dots (CQDs), an emerging nanomaterial, are gaining attention in ophthalmological applications due to their distinctive physical, chemical, and biological characteristics. For example, their inherent fluorescent capabilities offer a novel and promising alternative to conventional fluorescent dyes for ocular disease diagnostics. Furthermore, because of the excellent biocompatibility and minimal cytotoxicity, CQDs are well-suited for therapeutic applications. In addition, functionalized CQDs can effectively deliver drugs to the posterior part of the eyeball to inhibit neovascularization. This review details the use of CQDs in the management of ophthalmic diseases, including various retinal diseases, and ocular infections. While still in its initial phases within ophthalmology, the significant potential of CQDs for diagnosing and treating eye conditions is evident.

References

Calabrese G, De Luca G, Nocito G, Rizzo M, Lombardo S, Chisari G . Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors. Int J Mol Sci. 2021; 22(21). PMC: 8583729. DOI: 10.3390/ijms222111783. View

Sanni S, Moundzounga T, Oseghe E, Haneklaus N, Viljoen E, Brink H . One-Step Green Synthesis of Water-Soluble Fluorescent Carbon Dots and Its Application in the Detection of Cu. Nanomaterials (Basel). 2022; 12(6). PMC: 8952276. DOI: 10.3390/nano12060958. View

Zhang W, Chen J, Gu J, Bartoli M, Domena J, Zhou Y . Nano-carrier for gene delivery and bioimaging based on pentaetheylenehexamine modified carbon dots. J Colloid Interface Sci. 2023; 639:180-192. DOI: 10.1016/j.jcis.2023.02.046. View

Bourne R, Flaxman S, Braithwaite T, Cicinelli M, Das A, Jonas J . Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5(9):e888-e897. DOI: 10.1016/S2214-109X(17)30293-0. View

Wong W, Su X, Li X, Cheung C, Klein R, Cheng C . Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2):e106-16. DOI: 10.1016/S2214-109X(13)70145-1. View

Ferris 3rd F, Wilkinson C, Bird A, Chakravarthy U, Chew E, Csaky K . Clinical classification of age-related macular degeneration. Ophthalmology. 2013; 120(4):844-51. PMC: 11551519. DOI: 10.1016/j.ophtha.2012.10.036. View

Moon B, Kim Y, Kim S . Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment. Int J Mol Sci. 2023; 24(16). PMC: 10454953. DOI: 10.3390/ijms241613004. View

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

Yau J, Rogers S, Kawasaki R, Lamoureux E, Kowalski J, Bek T . Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35(3):556-64. PMC: 3322721. DOI: 10.2337/dc11-1909. View

10.

Resnikoff S, Pascolini D, Etyaale D, Kocur I, Pararajasegaram R, Pokharel G . Global data on visual impairment in the year 2002. Bull World Health Organ. 2005; 82(11):844-51. PMC: 2623053. DOI: /S0042-96862004001100009. View

11.

Varela-Fernandez R, Diaz-Tome V, Luaces-Rodriguez A, Conde-Penedo A, Garcia-Otero X, Luzardo-Alvarez A . Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations. Pharmaceutics. 2020; 12(3). PMC: 7151081. DOI: 10.3390/pharmaceutics12030269. View

12.

Geys J, Nemmar A, Verbeken E, Smolders E, Ratoi M, Hoylaerts M . Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect. 2008; 116(12):1607-13. PMC: 2599752. DOI: 10.1289/ehp.11566. View

13.

Hu C, Li M, Qiu J, Sun Y . Design and fabrication of carbon dots for energy conversion and storage. Chem Soc Rev. 2019; 48(8):2315-2337. DOI: 10.1039/c8cs00750k. View

14.

Lim S, Shen W, Gao Z . Carbon quantum dots and their applications. Chem Soc Rev. 2014; 44(1):362-81. DOI: 10.1039/c4cs00269e. View

15.

Bao H, Liu Y, Li H, Qi W, Sun K . Luminescence of carbon quantum dots and their application in biochemistry. Heliyon. 2023; 9(10):e20317. PMC: 10543222. DOI: 10.1016/j.heliyon.2023.e20317. View

16.

Rocco D, Georgian Moldoveanu V, Feroci M, Bortolami M, Vetica F . Electrochemical Synthesis of Carbon Quantum Dots. ChemElectroChem. 2023; 10(3):e202201104. PMC: 10369859. DOI: 10.1002/celc.202201104. View

17.

Farshbaf M, Davaran S, Rahimi F, Annabi N, Salehi R, Akbarzadeh A . Carbon quantum dots: recent progresses on synthesis, surface modification and applications. Artif Cells Nanomed Biotechnol. 2017; 46(7):1331-1348. DOI: 10.1080/21691401.2017.1377725. View

18.

Namdari P, Negahdari B, Eatemadi A . Synthesis, properties and biomedical applications of carbon-based quantum dots: An updated review. Biomed Pharmacother. 2017; 87:209-222. DOI: 10.1016/j.biopha.2016.12.108. View

19.

Hagiwara K, Horikoshi S, Serpone N . Photoluminescent Carbon Quantum Dots: Synthetic Approaches and Photophysical Properties. Chemistry. 2021; 27(37):9466-9481. DOI: 10.1002/chem.202100823. View

20.

Xin N, Gao D, Su B, Zhou T, Zhu Y, Wu C . Orange-Emissive Carbon Dots with High Photostability for Mitochondrial Dynamics Tracking in Living Cells. ACS Sens. 2023; 8(3):1161-1172. DOI: 10.1021/acssensors.2c02451. View